期刊文献+

子宫内膜异位症术后复发相关因素及保守治疗的疗效观察 被引量:14

下载PDF
导出
摘要 目的探讨子宫内膜异位症术后复发的相关危险因素,对比子宫内膜异位症复发患者口服避孕药和放置左炔诺孕酮宫内缓释系统治疗的疗效。方法收集整理因子宫内膜异位症行手术治疗的175例患者的临床资料,将其中复发50例患者随机分为2组:A组26例放置左炔诺孕酮宫内缓释系统,B组24例口服避孕药,记录治疗后的随访情况。结果患者的生育年龄、R-AFS评分高、保守性手术方式以及术后未用药治疗均为子宫内膜异位症术后复发的相关危险因素。A组患者治疗效果优于B组(P<0.05)。结论子宫内膜异位症术后复发的相关危险因素为年龄、期别、手术方式及术后是否药物治疗。复发患者放置左炔诺孕酮宫内缓释系统和口服避孕药均可有效控制子宫内膜异位症,缓解疼痛,降低CA125值,但放置左炔诺孕酮宫内缓释系统效果更佳。
作者 张文缓 侯丽
出处 《现代中西医结合杂志》 CAS 2013年第4期371-372,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

  • 1乐杰.妇产科学[M]北京:人民卫生出版社,2008325.
  • 2李华军,冷金花,郎景和,王惠兰,刘珠凤,孙大为,朱兰,丁小曼.子宫内膜异位症保守性手术后复发的相关因素分析[J].中华妇产科杂志,2005,40(1):13-16. 被引量:146
  • 3于传鑫;李诵舷.实用妇科内分泌学[M]上海:复旦大学出版社,2004157-158.
  • 4冯凤芝,郎景和,朱兰,金滢,冷金花,刘珠凤,孙大为.45岁以上子宫内膜异位症患者的临床特点及分析[J].实用妇产科杂志,2006,22(9):568-570. 被引量:15
  • 5郎景和.子宫内膜异位症研究的任务与展望(之二)[J].中华妇产科杂志,2006,41(10):649-651. 被引量:99
  • 6Vercellini P,Crosignani PG,Fadini R. Agonadotrophin-releasing hormone agonist compared with expectant management after conserveative surgery for symptomatic endometriosis[J].British Journal of Obstetrics and Gynaecology,1999,(07):672-677.
  • 7Vercellini P,Frontino G,De Giorgi O. Comparison of management after conservative surgery for symptomatic endometriesis:a Pilot study[J].Fertility and Sterility,2003,(08):305-309.
  • 8Backman T,Huhtala S,Luoto R. Advance information imp-roves users satisfaction with the levonorgestrel-releasing intrauterine system[J].Obstetrics and Gynecology,2002,(01):608-613.

二级参考文献18

  • 1Saleh A, Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration. Fertil Steril,1999,72 : 322-324.
  • 2Vercellini P, Crosignani PG, Fadini R, et al. A gonadotrophinreleasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol, 1999,106 : 672-677.
  • 3Busacca M, Marana R, Caruana P, et al. Recurrence of ovarian endometrioma after laparoscopic excision. Am J Obstet Gynecol,1999,180(3 Pt 1) : 519-523.
  • 4Chang CC, Lee HF, Tsai HD, et al. Sclerotherapy: an adjuvant therapy to endometriosis. Int J Gynaecol Obstet, 1997, 59:31-34.
  • 5Mittal S, Kumar S, Kumar A, et al. Ultrasound guided aspiration of endometrioma: a new therapeutic modality to improve reproductive outcome. Int J Gynaecol Obstet, 1999,65 : 17-23.
  • 6Ghezzi F, Beretta P, Franchi M, et al. Recurrence of ovarian endometriosis and anatomical location of the primary lesion. Fertil Steril, 2001,75 : 136-140.
  • 7Schindler AE, Foertig P, Kienle E, et al. Early treatment of endometriosis with GnRH-agonists: impact on time to recurrence.Eur J Obstet Gynecol Reorod Biol, 2000,93: 123-125.
  • 8Hurst BS, Gardner SC, Tucker KE, et al. Delayed oral estradiol combined with leuprolide increases endometriosis-related pain.JSLS, 2000, 4: 97-101.
  • 9Skenazi B,Warner ML.Epidemiology of endometriosis.Obstet Gynecol Clin North Am,1997,24(2):235~258.
  • 10Heaps JM,Nieberg RK,Berek JS.Malignant neoplasms arising in endometriosis.Obstet Gynecol,1990,75(6):1023~1028.

共引文献247

同被引文献128

引证文献14

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部